More on open access to data....In an August 12 op-ed piece in the NY Times, What You Do Know Can't Hurt You, Richard Friedman argues that drug companies routinely conceal studies showing adverse effects of their products. In his conclusion he calls for open access to the data generated by drug trials: "Public confidence in the safety and efficacy of S.S.R.I.'s, like all drugs, can be built only on full and representative disclosure of clinical research. To that end, the F.D.A. should publish on its Web site the results of all studies sponsored by drug companies. And for their part, drug companies should be required in their advertisements to list the number of trials that they conducted and published for each and every drug. These advertisements should also tell people how they can find the complete studies. For too long, drug companies have been allowed to tell us only the good news about their products. Now we're ready for the whole story." (Thanks to Ned Beach.)
Posted by
Peter Suber at 8/16/2003 05:24:00 PM.
The open access movement:
Putting peer-reviewed scientific and scholarly literature
on the internet. Making it available free of charge and
free of most copyright and licensing restrictions.
Removing the barriers to serious research.
